ABSTRACT
Recent studies have shown that the aryl hydrocarbon receptor (AhR) is expressed in the brain's native immune cells, known as microglia. However, while the impact of exposure to AhR ligands is well studied in the peripheral immune system, the impact of such exposure on immune function in the brain is less well defined. Microglia serve dual roles in providing synaptic and immunological support for neighboring neurons and in mediating responses to environmental stimuli, including exposure to environmental chemicals. Because of their dual roles in regulating physiological and pathological processes, cortical microglia are well positioned to translate toxic stimuli into defects in cortical function via aberrant synaptic and immunological functioning, mediated either through direct microglial AhR activation or in response to AhR activation in neighboring cells. Here, we use gene expression studies, histology, and two-photon in vivo imaging to investigate how developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a high-affinity and persistent AhR agonist, modulates microglial characteristics and function in the intact brain. Whole cortical RT-qPCR analysis and RNA-sequencing of isolated microglia revealed that gestational and lactational TCDD exposure produced subtle, but durable, changes in microglia transcripts. Histological examination and two-photon in vivo imaging revealed that while microglia density, distribution, morphology, and motility were unaffected by TCDD exposure, exposure resulted in microglia that responded more robustly to focal tissue injury. However, this effect was rectified with depletion and repopulation of microglia. These results suggest that gestational and lactational exposure to AhR ligands can result in long-term priming of microglia to produce heightened responses towards tissue injury which can be restored to normal function through microglial repopulation.
Subject(s)
Polychlorinated Dibenzodioxins , Female , Humans , Lactation , Ligands , Microglia/metabolism , Polychlorinated Dibenzodioxins/metabolism , Polychlorinated Dibenzodioxins/toxicityABSTRACT
Microglia, the immune cells of the brain, have a canonical role in regulating responses to neurological disease or injury, but have also recently been implicated as regulators of neurophysiological processes such as learning and memory. Given these dual immune and physiological roles, microglia are a likely mechanism by which external toxic stimuli are converted into deficits in neuronal circuitry and subsequently function. However, while it is well established that exposure to environmental toxicants negatively affects the peripheral immune system, it remains unknown whether and how such exposure causes neuroinflammation which, in turn, may negatively impact microglial functions in vivo. Here, we examined how acute 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in adulthood, which negatively impacts immune cells in the periphery, affects microglial characteristics in the cortex of the mouse. We found that microglia density, distribution, morphology, inflammatory signaling, and response to a secondary, pathological activation were unaffected by acute TCDD exposure. These results suggest that acute, peripheral TCDD exposure in adulthood is not sufficient to induce an overt inflammatory phenotype in cortical microglia.
Subject(s)
Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Environmental Pollutants/toxicity , Microglia/drug effects , Microglia/metabolism , Polychlorinated Dibenzodioxins/toxicity , Animals , Cerebral Cortex/pathology , Female , Male , Mice , Mice, Inbred C57BL , Microglia/pathologyABSTRACT
Oxidative stress (OS) is thought to participate in the pathogenesis of neurodegenerative disorders, including Parkinson's disease (PD). Excessive reactive oxygen species (ROS) production can occur during the normal aging process or following exposure to environmental toxicants. Dopamine neurons, which degenerate during PD, are particularly sensitive to oxidative stress. Polychlorinated biphenyls (PCBs), persistent and widespread pollutants, have been shown to adversely impact dopaminergic (DAergic) pathways, but the role ROS play in neurotoxicity remains unclear. To test the hypothesis that PCB exposure compromises dopamine neurons by stimulating ROS production, the direct toxicity and oxidative stress response following PCB exposure was examined both in MN9D dopamine cells and primary mesencephalic cultures. PCBs induced a time- and concentration-dependent increase in ROS production, which preceded cytotoxicity. Whereas intracellular GSH depletion exacerbated PCB effects, antioxidant pretreatment attenuated ROS production and cell death. Coincident alterations in antioxidant defense enzymes also accompanied ROS production, including decreased MnSOD and increased CuZnSOD protein levels. The robust elevation in heme oxygenase-1 levels further support the activation of oxidative stress mechanisms following PCB exposure. Furthermore, PCBs produced concentration-dependent reductions in intracellular dopamine levels and elevated dopamine turnover. Although the intracellular source of ROS remains unknown, these results suggest that sublethal PCB concentrations activate an oxidative stress-related pathway, which potentially disrupts dopamine neuron function.
Subject(s)
/pharmacology , Dopamine/metabolism , Neurons/drug effects , Oxidative Stress/drug effects , Animals , Antioxidants/metabolism , Cell Death/drug effects , Cell Death/physiology , Cells, Cultured , Dose-Response Relationship, Drug , Mesencephalon/drug effects , Mesencephalon/metabolism , Neurons/metabolism , Oxidative Stress/physiology , Rats , Rats, Sprague-DawleyABSTRACT
Evidence suggests the morphologic hallmark of gamma-diketone neuropathy is axon atrophy and that this effect is associated with reduced neurofilament (NF) subunit protein content (Toxicol Appl Pharmacol 2000;165:141-7). To investigate the mechanism of diminished NF content, subunit (NF-L, -M and -H) gene expression was quantified in dorsal root ganglion (DRG) of slightly affected and moderately intoxicated groups of rats exposed to 2,5-hexanedione (HD) at one of three daily dosing rates (175, 250 and 400 mg/kg per day). Results show that sensory ganglia from slightly affected rats exhibited no changes in gene expression, whereas at a moderate level of neurotoxicity, each dosing protocol was associated with small but significant reductions (approximately 20%) in mean NF subunit mRNA. This was not a generalized effect on expression of cytoskeletal components in sensory ganglia since tubulin message levels were not affected. Although the observed reduction in NF gene expression might be related to diminished levels of subunit proteins in peripheral nerve, the actual contribution is likely to be minimal. The magnitude of effect was small and did not correspond to the dose-rate dependent effect of HD on respective isotype proteins. The mechanism of gamma-diketone-induced axon atrophy is unknown but might involve local changes in axonal NF phosphorylation and degradation.
Subject(s)
Hexanones/toxicity , Neurofilament Proteins/biosynthesis , Neurofilament Proteins/genetics , Neurotoxins/toxicity , Peripheral Nervous System Diseases/chemically induced , Animals , Atrophy , Blotting, Northern , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Male , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Peripheral Nervous System Diseases/genetics , Peripheral Nervous System Diseases/metabolism , RNA/biosynthesis , RNA/isolation & purification , Rats , Rats, Sprague-DawleyABSTRACT
To assess the role of nicotinic cholinergic receptors (nAChR) on neuronal maturation, nAChR expression and the direct effects of nAChR activation were examined in cerebellar external granular layer (EGL) precursors isolated in vitro. Treatment of EGL neuroblasts with nicotine elicited a concentration-dependent increase in DNA content and synthesis, implying an increase in cell numbers. Pretreatment of cultures with the nAChR antagonist dihydro-beta-erythroidine (DHBE) attenuated nicotine-induced changes in DNA abundance and synthesis. Furthermore, chronic nicotine treatment for 4-7 days promoted EGL cell survival. Epibatidine but not cytisine stimulated granule neuroblast DNA synthesis and survival. Survival effects mediated by nicotine and epibatidine were attenuated by pretreating cultures with DHBE. Immunocytochemical analysis revealed that EGL neurons possessed alpha3, but not alpha4, nAChR immunoreactivity. Quantitative autoradiography was used to determine which nAChRs are present during the period of granule cell neurogenesis in vivo. On postnatal day 5, the EGL was intensely labelled by [3H]-epibatidine but virtually devoid of [3H]-A85380 binding, suggesting that a high concentration of alpha3 AChRs is present in granule neuroblasts. The pharmacology of [3H]-epibatidine displacement from EGL neurons also suggested an interaction with the alpha3-nAChR subunits. Together these data provide novel evidence that the activation of nAChRs directly affect the development of primary cerebellar neuroblasts and further suggest that the effects are mediated through the alpha3-nAChR subtype.
Subject(s)
Cerebellum/cytology , Cerebellum/drug effects , Neurons/physiology , Nicotine/pharmacology , Alkaloids/pharmacology , Animals , Azocines , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Cell Survival/drug effects , Cells, Cultured , Cellular Senescence/drug effects , DNA/metabolism , Mice , Mice, Inbred ICR , Neurons/drug effects , Nicotine/antagonists & inhibitors , Nicotinic Agonists/pharmacology , Protein Isoforms/metabolism , Pyridines/pharmacology , Quinolizines , Receptors, Cholinergic/metabolism , Stem Cells/metabolismABSTRACT
Seizures in adult rats result in long-term deficits in learning and memory, as well as an enhanced susceptibility to further seizures. In contrast, fewer lasting changes have been found following seizures in rats younger than 20 days old. This age-dependency could be due to differing amounts of hippocampal neuronal damage produced by seizures at different ages. To determine if there is an early developmental resistance to seizure-induced hippocampal damage, we compared the effects of kainic acid (KA)-induced status epilepticus and amygdala kindling on hippocampal dentate gyrus anatomy and electrophysiology, in immature (16 day old) and adult rats. In adult rats, KA status epilepticus resulted in numerous silver-stained degenerating dentate hilar neurons, pyramidal cells in fields CA1 and CA3, and marked numerical reductions in CA3c pyramidal neuron counts (-57%) in separate rats. Two weeks following the last kindled seizure, some, but significantly less, CA3c pyramidal cell loss was observed (-26%). Both KA status epilepticus and kindling in duced mossy-fiber sprouting, as evidenced by ectopic Timm staining in supragranular layers of the dentate gyrus. In hippocampal slices from adult rats, paired-pulse stimulation of perforant path axons revealed a persistent enhancement of dentate granule-cell inhibition following KA status epilepticus or kindling. While seizures induced by KA or kindling in 16-day-old rats were typically more severe than in adults, the immature hippocampus exhibited markedly less KA-induced cell loss (-22%), no kindling-induced loss, no detectable synaptic rearrangement, and no change in dentate inhibition. These results demonstrate that, in immature rats, neither severe KA-induced seizures nor repeated kindled seizures produce the kind of hippocampal damage and changes associated with even less severe seizures in adults. The lesser magnitude of seizure-induced hippocampal alterations in immature rats may explain their greater resistance to long-term effects of seizures on neuronal function, as well as future seizure susceptibility. Conversely, hippocampal neuron loss and altered synaptic physiology in adults may contribute to increased sensitivity to epileptogenic stimuli, spontaneous seizures, and behavioral deficits.
Subject(s)
Animals, Newborn/physiology , Hippocampus/pathology , Hippocampus/physiopathology , Kindling, Neurologic , Status Epilepticus/pathology , Status Epilepticus/physiopathology , Aging/physiology , Animals , Animals, Newborn/growth & development , Cell Count , Electric Stimulation/methods , Excitatory Amino Acid Agonists , Female , In Vitro Techniques , Kainic Acid , Male , Mossy Fibers, Hippocampal/pathology , Mossy Fibers, Hippocampal/physiology , Neural Inhibition , Neuronal Plasticity , Neurons/pathology , Perforant Pathway/physiopathology , Rats , Rats, Sprague-Dawley , Seizures/etiology , Seizures/pathology , Seizures/physiopathology , Status Epilepticus/chemically inducedABSTRACT
Exposure to a variety of agricultural, industrial, and pharmaceutical chemicals produces nerve damage classified as a central-peripheral distal axonopathy. Morphologically, this axonopathy is characterized by distal axon swellings and secondary degeneration. Over the past 25 years substantial research efforts have been devoted toward deciphering the molecular mechanisms of these presumed hallmark neuropathic features. However, recent studies suggest that axon swelling and degeneration are related to subchronic low-dose neurotoxicant exposure rates (i.e., mg toxicant/kg/day) and not to the development of neurophysiological deficits or behavioral toxicity. This suggests these phenomena are nonspecific and of uncertain pathophysiologic relevance. This possibility has significant implications for research investigating mechanisms of neurotoxicity, development of exposure biomarkers, design of risk assessment models, neurotoxicant classification schemes, and clinical diagnosis and treatment of toxic neuropathies. In this commentary we will review the evidence for the dose-related dependency of distal axonopathies and discuss how this concept might influence our current understanding of chemical-induced neurotoxicities.
Subject(s)
Axons/drug effects , Neurotoxins/administration & dosage , Polyneuropathies/chemically induced , Xenobiotics/administration & dosage , Animals , Axons/pathology , Dose-Response Relationship, Drug , Humans , Neurotoxins/toxicity , Polyneuropathies/pathology , Xenobiotics/toxicityABSTRACT
Quantitative morphometric analyses have demonstrated that axon atrophy is the primary neuropathic alteration in peripheral nerve of 2,5-hexanedione (HD)-intoxicated rats (Lehning et al., Toxicol. Appl. Pharmacol. 165, 127-140, 2000). Research suggests that axon caliber is regulated by neurofilament (NF) content and density. Therefore, as a possible mechanism of atrophy, NF subunit (NF-L, -M, and -H) proteins were quantitated in moderately affected rats intoxicated with HD at three daily dosing rates (175, 250, and 400 mg/kg/day). Analyses of subunit protein contents in proximal sciatic nerves indicated uniformly small decreases, which corresponded to minimal changes in axon area occurring in this region. In distal tibial nerve, subunit proteins were decreased substantially (40-70%) when rats were exposed to the 175 and 250 mg/kg/day doses. These reductions in NFs corresponded to significant decreases (approximately 50%) in tibial axon area induced by lower dosing rates. In contrast, 400 mg/kg/day produced similar changes in caliber but smaller reductions (18-25%) in NF-L, -M, and -H levels. This suggests that a decrement in axonal NF content is unlikely to be solely responsible for gamma-diketone-induced axon atrophy and that the corresponding mechanism probably involves additional changes in factors regulating NF density. Analysis of NF content in peripheral nerve also identified the presence of anomolous higher molecular weight NF-H proteins. However, the neurotoxicological significance of these abnormal subunits is uncertain based on their limited occurrence and inconsistent spatiotemporal expression.
Subject(s)
Hexanones/toxicity , Neurofilament Proteins/metabolism , Neurotoxins/toxicity , Peripheral Nervous System Diseases/chemically induced , Peripheral Nervous System Diseases/metabolism , Animals , Electrophoresis, Polyacrylamide Gel , Immunoblotting , Male , Molecular Weight , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/metabolism , Neurofilament Proteins/analysis , Neurofilament Proteins/isolation & purification , Peripheral Nervous System Diseases/pathology , Rats , Rats, Sprague-Dawley , Sciatic Nerve/drug effects , Sciatic Nerve/metabolism , Sciatic Nerve/pathology , Tibial Nerve/drug effects , Tibial Nerve/metabolism , Tibial Nerve/pathologyABSTRACT
The expression of heparin-binding epidermal growth factor-like growth factor (HB-EGF), an EGF receptor ligand, was investigated in rat forebrain under basal conditions and after kainate-induced excitotoxic seizures. In addition, a potential neuroprotective role for HB-EGF was assessed in hippocampal cultures. In situ hybridization analysis of HB-EGF mRNA in developing rat hippocampus revealed its expression in all principle cell layers of hippocampus from birth to postnatal day (P) 7, whereas from P14 through adulthood, expression decreased in the pyramidal cell layer versus the dentate gyrus granule cells. After kainate-induced excitotoxic seizures, levels of HB-EGF mRNA increased markedly in the hippocampus, as well as in several other cortical and limbic forebrain regions. In the hippocampus, HB-EGF mRNA expression increased within 3 hr after kainate treatment, continued to increase until 24 hr, and then decreased; increases occurred in the dentate gyrus granule cells, in the molecular layer of the dentate gyrus, and in and around hippocampal pyramidal CA3 and CA1 neurons. At 48 hr after kainate treatment, HB-EGF mRNA remained elevated in vulnerable brain regions of the hippocampus and amygdaloid complex. Western blot analysis revealed increased levels of HB-EGF protein in the hippocampus after kainate administration, with a peak at 24 hr. Pretreatment of embryonic hippocampal cell cultures with HB-EGF protected neurons against kainate toxicity. The kainate-induced elevation of [Ca2+]i in hippocampal neurons was not altered in cultures pretreated with HB-EGF, suggesting an excitoprotective mechanism different from that of previously characterized excitoprotective growth factors. Taken together, these results suggest that HB-EGF may function as an endogenous neuroprotective agent after seizure-induced neural activity/injury.
Subject(s)
Epidermal Growth Factor/genetics , Heparin , Hippocampus/metabolism , Neuroprotective Agents/metabolism , Seizures/metabolism , Animals , Female , Heparin-binding EGF-like Growth Factor , Hippocampus/drug effects , Intercellular Signaling Peptides and Proteins , Kainic Acid/toxicity , Male , Nerve Degeneration , Prosencephalon/drug effects , Prosencephalon/metabolism , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-DawleyABSTRACT
Endogenous opioids and opiate drugs of abuse inhibit the proliferation of cerebellar external granular layer (EGL) neuroblasts by mechanisms that are incompletely understood. Opioids do not act alone, rather multiple extracellular factors regulate granule cell neurogenesis and these undoubtedly act in concert with opioids to shape developmental outcome. We examined whether, heparin binding-epidermal growth factor-like growth factor (HB-EGF), a recently described member of the epidermal growth factor (EGF) family, might compete with an inhibitory opioid signal. The results confirmed our ongoing studies that morphine inhibited neuroblast proliferation, while HB-EGF enhanced cell replication. HB-EGF not only counteracted the antiproliferative morphine signal, but invariably enhanced DNA synthesis irrespective of morphine treatment. Our findings suggest that regional and temporal differences in the availability of endogenous HB-EGF may serve to limit the response of EGL neuroblasts to opioids, and HB-EGF may be neuroprotective in opiate drug abuse. If similar responses occur in vivo, then the EGF family and the opioid system may represent distinct and contrasting components of an extracellular signaling system serving to coordinate EGL neurogenesis.
Subject(s)
Cell Division/drug effects , Cerebellum/drug effects , Epidermal Growth Factor/pharmacology , Morphine/pharmacology , Narcotics/pharmacology , Neurons/drug effects , Animals , Animals, Newborn , Cell Survival/drug effects , Cerebellum/cytology , Cerebellum/physiology , DNA/metabolism , Heparin-binding EGF-like Growth Factor , Intercellular Signaling Peptides and Proteins , Mice , Neurons/physiologyABSTRACT
Pharmacologically distinct subpopulations of astroglia express mu, delta, and/or kappa opioid receptors. Activation of mu, delta, or kappa opioid receptors can destabilize intracellular calcium ([Ca2+]i) in astrocytes leading to cellular hypertrophy and reactive injury. To assess whether acute or sustained opioid exposure might adversely affect astroglial function by disrupting Ca2+ homeostasis or by producing reactive oxygen species, fura-2 and a novel fluorescent-tagged biotin-4-amidobenzoic hydrazide reagent, respectively, were used to detect [Ca2+]i and carbonyl oxidation products within individual murine astrocytes. Acute (3 h) exposure to mu; (H-Tyr-Pro-Phe (N-Me) -D-Pro-NH2; PLO17), delta ([D-Pen2, D-Pen5]-enkephalin), and kappa (trans-(+/-)-3, 4-dichloro-N-methyl-N-[2-(1-pyrr olidinyl) cyclohexyl] benzeneacetamide methanesulfonate; U50,488H) opioid agonists caused significant mean increases in [Ca2+]i and in the levels of oxidative products in astrocytes. In contrast, following 72 h of continuous opioid exposure, [Ca2+]i and carbonyl levels returned to normal, irrespective of opioid treatment. These preliminary findings indicate that opioids initially destabilize [Ca2+]i and increase reactive oxygen species in astrocytes; however, astrocytes later recover and adapt to sustained opioid exposure.
Subject(s)
Astrocytes/metabolism , Calcium/metabolism , Homeostasis/drug effects , Narcotics/pharmacology , Reactive Oxygen Species/metabolism , 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer/pharmacology , Analgesics/pharmacology , Analgesics, Non-Narcotic/pharmacology , Animals , Astrocytes/chemistry , Astrocytes/drug effects , Drug Tolerance , Endorphins/pharmacology , Enkephalin, D-Penicillamine (2,5)- , Enkephalins/pharmacology , Mice , Mice, Inbred ICR , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Oxidative Stress/drug effects , Receptors, Opioid, delta/antagonists & inhibitors , Receptors, Opioid, kappa/antagonists & inhibitors , Receptors, Opioid, mu/antagonists & inhibitorsABSTRACT
Astroglial cells are resistant to cell death and morphologic damage following lead (Pb) exposure at concentrations which elicit detrimental effects in neurons. A possible explanation may be that astroglial cells respond to Pb by increasing the expression of specific proteins, such as heat-shock proteins (HSPs), which confer resistance to low levels of Pb. However, there has been relatively limited information regarding the ability of Pb to evoke the synthesis of HSPs. In the current study, pulse-labeling of cultured astroglial proteins with [3H]-leucine was used to evaluate the nature of Pb-induced changes in protein expression. The effect of Pb on newly synthesized proteins was compared to the response elicited by heat-shock and oxidative injury. Immunoblot analysis was utilized to examine alterations in levels of various stress proteins including HSP27, HSP70, HSP90, and heme oxygenase-1 (HO-1). Even though Pb induced the synthesis of proteins with estimated molecular weights of 23 kDa, 32 kDa, 70 kDa, and 90 kDa, the accumulation of HSPs other than HO-1 was not observed. Hyperthermia and treatment with Na arsenite both resulted in enhanced expression of HSP70 and HO-1. In addition, exposure to hydrogen peroxide (H2O2), cadmium (Cd), and lipopolysaccharide (LPS) stimulated a rise in HO-1 levels. Although cellular insult failed to elicit an increase in either HSP27 or HSP90, cultured astroglia expressed readily detectable levels of both these proteins. Furthermore, Pb exposure resulted in the development of crosstolerance to subsequent injury by treatment with either Cd or H2O2. The results of this study indicate that Pb triggers a less conventional stress response in astroglial cells, which may provide enhanced resistance to the toxic effects of Pb.
Subject(s)
Astrocytes/metabolism , Heat-Shock Proteins/biosynthesis , Heme Oxygenase (Decyclizing)/biosynthesis , Lead/pharmacology , Animals , Arsenites/pharmacology , Astrocytes/cytology , Astrocytes/drug effects , Cadmium/pharmacology , Cells, Cultured , HSP70 Heat-Shock Proteins/biosynthesis , Hot Temperature , Hydrogen Peroxide/pharmacology , Lipopolysaccharides/pharmacology , Oxidative Stress/physiology , Rats , Rats, Sprague-DawleyABSTRACT
Although astroglial cells accumulate lead (Pb), they appear to be less sensitive to its overt deleterious effects than are neurons. One possible mechanism in which as rocytes adapt to Pb may be by upregulating the expression of particular genes. This study evaluated the effect of exogenous Pb on proteins synthesized in primary rat astroglial cultures. Following incubations with 0-50 microM Pb acetate cells were radiolabeled with leucine for various time intervals. Proteins were subsequently analyzed using SDS-PAGE followed by fluorography. Changes observed within the first 24 hr resembled a classical stress response and included increased synthesis of proteins with apparent molecular weights of 90, 70, 32-35, and 23 kDa. The most notable change was the enhanced synthesis and abundance of the 23-kDa protein (p23) which persisted throughout a 14-day treatment period, whereas the synthesis of the other proteins declined. This protein did not appear to be induced in rat lung fibroblasts treated with similar concentrations of Pb. Subcellular fractionation indicated that p23 was localized to the cytosol. Treatment with actinomycin D or cycloheximide prior to the addition of Pb precluded induction of p23. Pulse labeling of cells following a 24-hr Pb exposure revealed that p23 continued to be synthesized for 12 but not 24 hr following removal of Pb. Pulse-chase experiments indicated that the protein was stable for at least 18 hr following the removal of Pb. Two-dimensional gel electrophoresis revealed that the 23-kDa Pb-induced protein consisted of multiple-charged species with pl values ranging from 4.3 to 7.8.